National Institute on Drug Abuse

The National Institute on Drug Abuse (NIDA) is a U.S. federal research institute within the National Institutes of Health (NIH) focused on the science of drug use and addiction. NIDA funds and sponsors clinical trials examining the therapeutic potential of psychedelic and dissociative compounds, particularly around substance use disorders.

National Institute on Drug Abuse

Quick Facts

Sponsored Trials

Neurobiology and Pharmacokinets of Acute MDMA Administration

Collaborated Trials

Drug Effects on Mood and Behavior – Expectancy (MESA-X)

Psilocybin for Opioid Use Disorder (OUD)

Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)

Prosocial Effects of MDMA (PEM)

The Effects of Sedatives on Tobacco Use Disorder Version 2 (SED-TUD2)

5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder

Stanford Reward Circuits of the Brain Study – MDMA

Ketamine for the Treatment of Opioid Use Disorder and Depression

Mood Effects of Serotonin Agonists Extended

Persisting Effects of Psilocybin

Trial of Ketamine and Lithium Therapy in Bipolar Depression

Effects of MDMA on Social and Emotional Processing

Effects of Salvinorin A on Brain Function

Human Psychopharmacology of Salvinorin A

Methylenedioxymethamphetamine (MDMA, Ecstasy) Induced Changes in Drug Metabolism: Gender and Genetic Polymorphisms

Company

Product

Legal